This invention provides for a flow synthesis process for producing Oseltamivir and pharmaceutically acceptable salts thereof from shikimic acid in particular but not exclusively to a flow synthesis process for producing Oseltamivir phosphate from shikimic acid in a nine-step flow synthesis that provides for superior reaction times and product yields compared to known methods.

The invention relates to a process for producing compounds containing at least one arylamino group by means of a palladium-catalysed coupling reaction of an arylamino compound with an aryl compound, using LiOtBu as a base.

The invention relates to a process for producing compounds containing at least one arylamino group by means of a palladium-catalysed coupling reaction of an arylamino compound with an aryl compound, using LiOtBu as a base.

The present disclosure provides a new and improved process for preparation of intermediate compounds and synthesis of mesotrione therefrom. The present disclosure provides an economical, efficient and eco-friendly process for preparation of mesotrione.

The present disclosure provides a new and improved process for preparation of intermediate compounds and synthesis of mesotrione therefrom. The present disclosure provides an economical, efficient and eco-friendly process for preparation of mesotrione.

The present application provides ligands and fluorescent or luminescent complexes comprising these ligands.

The present application provides ligands and fluorescent or luminescent complexes comprising these ligands.

The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in .sup.18F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in .sup.18F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in .sup.18F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.